Roche says data in hepatitis treatment encouraging

ZURICH Thu Apr 19, 2012 11:06am IST

Related Topics

Stocks

   

ZURICH (Reuters) - Swiss drugmaker Roche said on Thursday initial data on a protease inhibitor, danoprevir, is encouraging against Hepatitis C.

"The high sustained viral response rates and encouraging safety data show danoprevir is potent and well-tolerated," Roche development head Hal Barron said in a statement.

"Roche's HCV portfolio includes multiple investigational drugs with different modes of action, allowing us to develop tailored treatments that aim to address the future needs of patients with chronic hepatitis C," Barron said.

(Reporting By Katharina Bart)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

EBOLA

REUTERS SHOWCASE

Fighting Hunger

Fighting Hunger

Hunger easing globally but 1 in 9 people undernourished: report.  Full Article 

Whooping Cough

Whooping Cough

Parents' whooping cough vaccines may protect babies.  Full Article 

Leg Pain

Leg Pain

Chiropractic care may ease back-related leg pain.  Full Article 

Fitness Tip

Fitness Tip

To make the most of a workout, experts say set the proper pace.  Full Article 

E-cigarettes

E-cigarettes

As Big Tobacco takes up e-cigarettes, investors look ahead.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage